A new class of serotonin 5‐HT 2A /5‐HT 2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins-Reference-Cited by-同舟云学术

A new class of serotonin 5‐HT 2A /5‐HT 2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins

Published:2021-11-26 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Casey Austen B.¹²³,Mukherjee Munmun¹²³,McGlynn Ryan P.¹²³^ORCID,Cui Meng¹²,Kohut Stephen J.¹²⁴,Booth Raymond G.¹²³

Affiliation:

1. Center for Drug Discovery Northeastern University Boston Massachusetts United States

2. Department of Pharmaceutical Sciences Northeastern University Boston Massachusetts United States

3. Department of Chemistry & Chemical Biology Northeastern University Boston Massachusetts United States

4. Behavioral Neuroimaging Laboratory, McLean Hospital and Department of Psychiatry Harvard Medical School Belmont Massachusetts United States

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15756

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation;European Journal of Pharmacology;2024-03

2. Synthesis and in vitro evaluation of novel amino-phenylmethylene-imidazolone 5-HT_2A receptor antagonists;RSC Medicinal Chemistry;2024

3. Development of 2-Aminotetralin-Type Serotonin 5-HT₁ Agonists: Molecular Determinants for Selective Binding and Signaling at 5-HT_1A, 5-HT_1B, 5-HT_1D, and 5-HT_1F Receptors;ACS Chemical Neuroscience;2023-12-27

4. Effects of (−)‐MBP, a novel 5‐HT_2C agonist and 5‐HT_2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice;Pharmacology Research & Perspectives;2023-10

5. Design, Synthesis, Molecular Docking, and Biological Evaluation of Novel Pimavanserin-Based Analogues as Potential Serotonin 5-HT_2A Receptor Inverse Agonists;Journal of Medicinal Chemistry;2023-06-28